Johnson & Johnson
Részvény piaci hírek
- Sun, 25 Feb 2018 17:00:00 +0000 Pharma Must Use Tax-Reform Windfall To Make More Drugs Or Face Backlash - Part II
- Sat, 24 Feb 2018 05:01:00 +0000 [$$] MKM Raises Amazon.com Price Target by 30%
- Sat, 24 Feb 2018 00:09:00 +0000 3 Big Drugmakers Boosting Huge R&D Budgets
- Fri, 23 Feb 2018 19:37:00 +0000 JNJ INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Johnson & Johnson and a Lead Plaintiff Deadline of April 9, 2018
- Fri, 23 Feb 2018 18:32:29 +0000 Stocks are coiling for the next big move
- Fri, 23 Feb 2018 17:15:00 +0000 Pawar Law Group Announces That a Class Action Lawsuit Has Been Filed On Behalf of Shareholders Who Purchased Shares of Johnson & Johnson (NYSE: JNJ) Between February 22, 2013 and February 7, 2018, Both Dates Inclusive
- Fri, 23 Feb 2018 15:40:04 +0000 How Johnson & Johnson’s Infectious Diseases Portfolio Perform in 2017
- Fri, 23 Feb 2018 14:47:48 +0000 Can brands force fix of social media's problems?
- Fri, 23 Feb 2018 14:19:02 +0000 Achillion (ACHN) Q4 Loss Widens, Plans Job Cuts to Save Cost
- Fri, 23 Feb 2018 14:09:12 +0000 Johnson & Johnson’s Simponi Could See Steady Growth in 2018
- Fri, 23 Feb 2018 12:45:42 +0000 Performance of Johnson & Johnson’s Remicade and Stelara in 2017
- Fri, 23 Feb 2018 12:17:00 +0000 3 Top Dividend Stocks With Yields Over 2%
- Fri, 23 Feb 2018 00:01:00 +0000 Jim Cramer: You Have to Decide If You Want to Profit From This Moment
- Thu, 22 Feb 2018 19:50:03 +0000 JNJ’s Consumer Products: OTC, Women’s Health, and Wound Care
- Thu, 22 Feb 2018 19:15:57 +0000 JNJ SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Johnson & Johnson and a Lead Plaintiff Deadline of April 9, 2018
- Thu, 22 Feb 2018 18:33:00 +0000 INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Johnson & Johnson To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
- Thu, 22 Feb 2018 18:20:03 +0000 Update on JNJ’s Consumer Products: Baby Care, Beauty, and Oral Care
- Thu, 22 Feb 2018 18:15:07 +0000 Abbott Laboratories’ 377th Consecutive Quarterly Dividend
- Thu, 22 Feb 2018 17:55:35 +0000 A Look at Eli Lilly’s 4Q17 Revenue
- Thu, 22 Feb 2018 16:47:29 +0000 How Johnson & Johnson Performed in 4Q17 and Fiscal 2017
Információk a cégről
Johnson & Johnson is an American manufacturer of consumer health care products, prescription and pharmaceutical products, as well as medical devices and diagnostic products. The company produces a wide range of cosmetic and sanitary products, under the brands Johnson’s Baby, Neutrogena, OB, Carefree, Reach, Clean & Clear, RoC, Band Aid and Acuvue, among others.
Johnson & Johnson operates three divisions:
- Consumer Products (baby care, cosmetic products for face, hair and body, personal hygiene, non-prescription drugs).
- Medical devices and diagnostics (products and solutions in the field of cardiology, cardiovascular surgery, endocrinology, traumatology, orthopedics, ophthalmology, wound care, plastic surgery, sports medicine, sterilization and disinfection, minimally invasive surgery and diagnostics).
- Prescription products (solutions to serious medical problems in the fields of oncology, immunology and psychiatry, as well as for infectious diseases, cardiovascular diseases and metabolic disorders).
The company is investing heavily on the development of medical technology and advanced methods of treatment, on the research of new drugs, on enhanced quality and safety of products and techniques, on the development of vocational education of health professionals, as well as on social and charity projects.
Number of employees: 128,000
Year of establishment: 1886
Headquarters: New Brunswick, New Jersey, United States
Official site: www.jnj.com